← Back to opportunities

Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult

MEDICINES DISCOVERY CATAPULT LIMITED

Buyer Contact Info

Buyer Name: MEDICINES DISCOVERY CATAPULT LIMITED

Buyer Address: Block 35g, Mereside Alderley Park, Macclesfield, UKD62, SK10 4ZF, United Kingdom

Contact Email: procurement@md.catapult.org.uk

Status
complete
Procedure
direct
Value
344000.0 GBP
Published
08 Dec 2025, 14:22
Deadline
n/a
Contract Start
17 Dec 2025, 00:00
Contract End
17 Dec 2026, 23:59
Category
n/a
CPV
38000000 - Laboratory, optical and precision equipments (excl. glasses)
Region
n/a
Awarded To
10x Genomics Inc
Official Source
Open Find a Tender

Description

..

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot 1 Status: complete

Documents

Document Description: Not published

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2026-12-17T23:59:59Z",
        "maxExtentDate": "2030-12-18T23:59:59Z",
        "startDate": "2025-12-17T00:00:00Z"
      },
      "documents": [
        {
          "datePublished": "2025-12-08T14:22:22Z",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "080646-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/080646-2025"
        }
      ],
      "hasOptions": true,
      "hasRenewal": true,
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Laboratory, optical and precision equipments (excl. glasses)",
              "id": "38000000",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UK"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-12-17T23:59:59Z",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "options": {
        "description": "The contract may be extended to purchase four 12 month warranty extensions."
      },
      "relatedLots": [
        "1"
      ],
      "renewal": {
        "description": "The contract may be extended for a further four twelve month periods to extend the original warranty."
      },
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-PPON-PBMJ-4568-WMPX",
          "name": "10x Genomics Inc"
        }
      ],
      "value": {
        "amount": 344000,
        "amountGross": 412800,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-COH-09928547",
    "name": "MEDICINES DISCOVERY CATAPULT LIMITED"
  },
  "date": "2025-12-08T14:22:22Z",
  "id": "080646-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05f0dd",
  "parties": [
    {
      "additionalIdentifiers": [
        {
          "id": "PJPQ-6911-DQYY",
          "scheme": "GB-PPON"
        }
      ],
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Macclesfield",
        "postalCode": "SK10 4ZF",
        "region": "UKD62",
        "streetAddress": "Block 35g, Mereside Alderley Park"
      },
      "contactPoint": {
        "email": "procurement@md.catapult.org.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ]
      },
      "id": "GB-COH-09928547",
      "identifier": {
        "id": "09928547",
        "scheme": "GB-COH"
      },
      "name": "MEDICINES DISCOVERY CATAPULT LIMITED",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "US",
        "countryName": "United States",
        "locality": "Pleasanton",
        "postalCode": "CA 94588-3260",
        "region": "US",
        "streetAddress": "6230 Stoneridge Mall Road"
      },
      "contactPoint": {
        "email": "tenders@10xgenomics.com"
      },
      "details": {
        "scale": "large",
        "url": "https://www.10xgenomics.com/",
        "vcse": false
      },
      "id": "GB-PPON-PBMJ-4568-WMPX",
      "identifier": {
        "id": "PBMJ-4568-WMPX",
        "scheme": "GB-PPON"
      },
      "name": "10x Genomics Inc",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "..",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "ocds-h6vhtk-05f0dd",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics, on the basis that no reasonable alternative or substitute exists which meets the specific technical and operational requirements of the organisation.\nIndependent comparative studies have demonstrated that alternative platforms currently on the market exhibit significantly higher levels of background noise, reducing data quality in single cell spatial analysis. MDC has verified these performance results and determined that the Xenium system is uniquely capable of delivering the sensitivity and precision required for our research and service activities.\nBeyond this the Xenium platform also offers operational advantages. It enables the use of panels with a low minimum run size, which aligns closely with the typical experimental scale within MDC. Competing systems require substantially higher minimum slide numbers, making them unsuitable and leading to inefficient use of resources.\nIn addition, acquiring the Xenium system will strengthen MDC\u0027s national role by providing UK drug discovery organisations access to a capability that is not currently available within any UK based CRO. This avoids duplication with existing commercial provider and ensures MDC can offer new and complementary capabilities to the wider life sciences community.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "title": "Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult"
  }
}